Results 101 to 110 of about 1,094,334 (317)
Chronic hepatitis may be viral or "lupoid" or may be related to drug use, alcoholism, or Wilson's disease. This article outlines the routine and special laboratory investigations that are indicated when the presence of chronic hepatitis is suspected from symptoms referable to the liver or from biochemical or physical abnormalities in an asymptomatic ...
openaire +5 more sources
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients [PDF]
Background: Whereas it is well established that various soluble biomarkers can predict level of liver fibrosis, their ability to predict liver-related clinical outcomes is less clearly established, in particular among HIV/viral hepatitis co-infected ...
Soriano, V +38 more
core +3 more sources
Hepatic encephalopathy (HE) is a reversible syndrome of impaired brain function occurring in patients with advanced liver diseases. The precise pathophysiology of HE is still under discussion; the leading hypothesis focus on the role of neurotoxins, impaired neurotransmission due to metabolic changes in liver failure, changes in brain energy metabolism,
openaire +5 more sources
Objective Race and household income impact outcomes in patients with rheumatic conditions; however, their role in pediatric antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) remains poorly understood. We aimed to evaluate whether race and ethnicity and household income are associated with severe AAV disease and renal outcomes among
Roberto Alejandro Valdovinos +2 more
wiley +1 more source
Dose adaptation of drugs in patients with liver disease [PDF]
A detailed introduction into the topic was obtained by developing a German-language online course named “Dose adjustment in Patients with Liver Disease” for the “Swiss Virtual Campus” in collaboration with PNN AG, a spin-off company of the ETH Zurich.
Schlatter-Häner, Chantal
core +1 more source
IntroductionAE and whether the inhibition of the MyD88 inflammatory pathway can enhance Ghrelin expression to collaboratively modulate AE progression remains unclear.MethodsIn this study, we evaluated Ghrelin serum levels and changes in TLR4/MyD88/NF-κB ...
Jiang Zhu +18 more
doaj +1 more source
Kunlei Zhu,* Tong Zhu,* Changyou Jing, Yonghong Zhang, Jianjun Li Hepatic Disease and Oncology Minimally Invasive Interventional Center, Beijing YouAn Hospital, Capital Medical University, Beijing, People’s Republic of China*These
Zhu K, Zhu T, Jing C, Zhang Y, Li J
doaj
Molecular Characterization of Echinococcus vogeli from Human Case, Colombia, 2024
In Colombia, 35 confirmed cases of neotropical polycystic echinococcosis were reported during 1978–2018. In most cases, Echinococcus vogeli was identified by means of morphologic identification. We describe a case of E. vogeli echinococcosis in a woman,
Jorge Alfredo Morcillo Muñoz +8 more
doaj +1 more source
Right isomerism, also known as Ivemark syndrome, is an unusual degree of symmetry of some of the abdominothoracic viscera reflecting bilateral right-sidedness. We report an exceedingly rare occurrence of anomalous drainage of the left hepatic vein to the
Ishan Kumar +3 more
doaj +1 more source

